Byetta Warnings Stir Interest Of Plaintiffs Bar

Law360, New York (August 22, 2008, 12:00 AM EDT) -- Plaintiffs lawyers are already taking legal action in the wake of the U.S. Food and Drug Administration's announcement Monday that stronger warnings will be added to the label of Amylin Pharmaceuticals Inc.'s Byetta after reports of two deaths linked to the injectable diabetes medication.

The FDA's heightened safety warning came after the agency said it had received reports of six cases of severe pancreatitis in patients taking Byetta — a drug given by injection twice a day to adults with Type 2 diabetes — and was...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.